Ophthalmology
A study aimed to assess RIPK3 inhibition in acute glaucoma using AI.
The combo's use for conjunctival melanoma demonstrates the combinations high efficacy in treating complex disease.
Mr. Dermott Ryan, a patient with Demodex blepharitis, provides firsthand insight on the impact of the disease.
Eye care experts provide a physician-focused perspective on the current treatment paradigm for Demodex blepharitis.
A panel of experts discusses lotilaner ophthalmic solution 0.25%, the first FDA-approved treatment for Demodex blepharitis.
An ophthalmology panel explains the pros and cons of the current standard of care for treating Demodex blepharitis.
Advertisement
Expert Interviews on Ophthalmology
Ehsan Rahimy, MD, moderates a discussion about hands-on experience with port delivery systems for patients with ...
In this segment of the round table series, moderator Ehsan Rahimy, MD, and panelists discuss the findings from the ...
The panel discusses the advancements they are most looking forward to in the neovascular AMD space, from new treatments ...
A recent survey conducted by The Harris Poll on behalf of Apellis Pharmaceuticals found that geographic atrophy (GA) – ...
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.